Category Archives: US pressure on India

Indian pharma industry fears tougher US stance on IP

Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US By Aneesh Phadnis & Reuters| Published: Business Standard | february 1, 2017 Indian pharma industry is fearing a tougher US government stance on intellectual … Continue reading

Posted in Generics, IPR, Uncategorized, US pressure on India | Leave a comment

Compulsory licensing: India gave ‘private reassurance’, says US business council

In a review submitted to USTR, four US industry bodies have said that India has developed a “positive” approach over the compulsory licensing issue.  Written by Liz Mathew, The Indian Express | New Delhi | March 8, 2016 The US-India … Continue reading

Posted in Compulsory Licensing, Special 301 report, Uncategorized, US pressure on India | Leave a comment

Generic drugs: ‘India must give written declaration on compulsory licensing’

A bilateral investment pact would be beneficial to both India and the US: USIBC President Nayanima Basu, The Hindu BusinessLine|February 17, 2016 Mukesh Aghi, President, US-India Business Council (USIBC), said although India has given verbal assurance on not issuing compulsory … Continue reading

Posted in Compulsory Licensing, Uncategorized, US pressure on India | Leave a comment

PhRMA Special 301 submission 2016

PhRMA Special 301 Submission 2016 insists that India remains on the Priority Watch List in the USTR Special 301 Report. PhRMA sees India’s progressive Patent Act of 2005 and IP environment as a legal and regulatory barrier to patentability of … Continue reading

Posted in Special 301 report, US pressure on India | Leave a comment

No respite for Big Pharma on patents

FINANCIAL EXPRESS| By Banikinkar Pattanayak on December 30, 2015 Dilution of Section 3(d), compulsory licensing unlikely despite US concerns Disappointed with India’s new National IPR Policy, the US has upped the ante for a world-class patenting regime in India, but … Continue reading

Posted in Compulsory Licensing, IPR policy, Sec 3 (d), TRIPS, TRIPS plus, US pressure on India | Tagged , , , , , | Leave a comment

Barack Obama to attend Asean meeting

The Sun Daily; November 16, 2015. Kuala Lumpur –  US president Barack Obama will be among the big names who will be here this week to attend the 27th annual Asean meeting between Nov 18 and 22. Other leaders who have confirmed attendance … Continue reading

Posted in Asean, Regional Comprehensive Economic Partnership, US pressure on India | Leave a comment

Away from the Glare, a Push for More Stringent IPR Protection at the WTO

The Wire; November 2, 2015. By Priti Patnaik. The United States and Switzerland want the right to file complaints for loss of trade ‘benefits’ even against countries whose intellectual property rights laws are fully consistent with international agreements.

Posted in Non-violation complaints, TRIPS, US pressure on India, WTO | Leave a comment